# Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery

> **NCT00613418** · NA · WITHDRAWN · sponsor: **Abbott Medical Devices**

## Conditions studied

- With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries

## Interventions

- **DEVICE:** IDev SUPERA® Interwoven Self Expanding Nitinol Stent Peripheral Vascular System

## Key facts

- **NCT ID:** NCT00613418
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study did not move forward due to change in clinical strategy
- **Last updated:** 2019-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613418, "Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00613418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*